Table 1 |
||||
| Basic characteristics of study subjects (n = 513) | ||||
| Variable | Mean | Male (n = 266) | Female (n = 247) | P |
| Age (years) | 59.1 ± 7.0 | 59.3 ± 6.9* | 58.8 ± 7.0 | 0.226 |
| Hypertension, n (%) | 146 (28.5) | 85 (32.0) | 61(24.7) | 0.069 |
| Diabetes, n (%) | 49 (9.6) | 28 (10.5) | 21 (8.5) | 0.436 |
| Waist circumference (cm) | 80.0 ± 8.6 | 84.0 ± 7.6 | 75.6 ± 7.3 | < 0.001 |
| Central obesity, n (%) | 114 (22.2) | 50 (18.8) | 64 (25.9) | 0.053 |
| Hip circumference (cm) | 92.5 ± 5.4 | 92.4 ± 5.3 | 92.6 ± 5.4 | 0.692 |
| Waist-to-hip ratio (%) | 86.4 ± 7.2 | 91.7 ± 5.4 | 81.7 ± 5.9 | < 0.001 |
| WHtR (%) | 49.8 ± 4.9 | 50.6 ± 4.5 | 48.9 ± 5.1 | < 0.001 |
| BMI (kg/m2) | 24.2 ± 3.0 | 24.5 ± 2.7 | 23.9 ± 3.0 | 0.005 |
| Body adiposity index | 27.6 ± 3.9 | 25.2 ± 2.7 | 30.1 ± 3.4 | < 0.001 |
| Systolic blood pressure (mmHg) | 130 ± 19 | 128 ± 18 | 132 ± 20 | 0.007 |
| Diastolic blood pressure (mmHg) | 76 ± 12 | 79 ± 11 | 72 ± 12 | < 0.001 |
| Total cholesterol (mM) | 5.09 ± 0.92 | 4.97 ± 0.96 | 5.21 ± 0.85 | 0.001 |
| Total cholesterol ≥ 6.22 mM, n (%) | 52 (10.1) | 21 (7.9) | 31 (12.6) | 0.081 |
| HDL-C (mM) | 1.40 ± 0.39 | 1.28 ± 0.36 | 1.52 ± 0.39 | < 0.001 |
| HDL-C < 0.9 mM in men or < 1.03 mM in women, n (%) | 128 (25.0) | 54 (20.3) | 74 (30.0) | 0.012 |
| Triglyceride (mM) | 1.33 ± 0.78 | 1.42 ± 0.85 | 1.22 ± 0.70 | 0.002 |
| Triglyceride ≥ 1.70 mM, n (%) | 121 (23.6) | 70 (26.3) | 51 (20.6) | 0.131 |
| Fasting glucose (mM) | 5.25 ± 1.08 | 5.29 ± 1.10 | 5.19 ± 1.05 | 0.127 |
| Fasting glucose ≥ 5.6 mM, n (%) | 95 (18.5) | 56 (21.1) | 39 (15.8) | 0.125 |
| MS-TW, n (%) | 105 (20.5) | 52 (19.5) | 53 (21.5) | 0.592 |
| LAP | 25.9 ± 21.6 | 23.0 ± 23.2 | 28.6 ± 19.3 | 0.001 |
*Values are mean ± standard deviation except otherwise denoted.
Central obesity: waist circumference ≥ 90 cm in males and ≥ 80 cm in females.
Body adiposity index: (hip circumference/height1.5) − 18.
Hypertension: subjects with a history of hypertension or using antihypertensive medications.
HDL-C high-density lipoprotein cholesterol, MS-TW: metabolic syndrome criteria for Taiwanese, WHtR waist-to-height ratio, BMI body mass index, LAP lipid accumulation product.
Chiang and Koo BMC Cardiovascular Disorders 2012 12:78 doi:10.1186/1471-2261-12-78
